| |
| |
|
| Insider
Information: |
Kulkarni Samarth |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
208,122 |
|
|
Indirect Shares
|
200,000 |
|
|
| Direct
Value |
$11,644,426 |
|
|
|
Indirect Value
|
$11,190,000 |
|
|
| Total
Shares |
408,122 |
|
|
| Total
Value |
$22,834,426 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -67.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
|
2024-04-15 |
208,122 |
2024-04-15 |
200,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
113 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-26 |
4 |
OE |
$1.81 |
$5,928 |
D/D |
3,275 |
137,322 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-24 |
4 |
AS |
$16.46 |
$57,619 |
D/D |
(3,500) |
134,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-24 |
4 |
OE |
$1.81 |
$6,335 |
D/D |
3,500 |
137,547 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-08-30 |
4 |
AS |
$20.00 |
$80,000 |
D/D |
(4,000) |
106,893 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-03-14 |
4 |
D |
$61.08 |
$253,665 |
D/D |
(4,153) |
290,279 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-19 |
4 |
OE |
$1.81 |
$7,796 |
D/D |
4,307 |
175,833 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-19 |
4 |
AS |
$65.16 |
$280,644 |
D/D |
(4,307) |
171,526 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-12 |
4 |
S |
$74.44 |
$341,159 |
D/D |
(4,583) |
208,122 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-25 |
4 |
OE |
$1.81 |
$9,258 |
D/D |
5,115 |
139,162 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-25 |
4 |
AS |
$16.87 |
$86,290 |
D/D |
(5,115) |
134,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
D |
$62.56 |
$343,267 |
D/D |
(5,487) |
285,432 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-03-10 |
4 |
D |
$124.15 |
$686,053 |
D/D |
(5,526) |
188,498 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-02-20 |
4 |
S |
$79.67 |
$507,498 |
D/D |
(6,370) |
194,257 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-02-21 |
4 |
D |
$48.26 |
$307,561 |
D/D |
(6,373) |
375,988 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-19 |
4 |
OE |
$1.81 |
$13,137 |
D/D |
7,258 |
141,305 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-19 |
4 |
AS |
$17.54 |
$129,754 |
D/D |
(7,258) |
134,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-12-16 |
4 |
OE |
$1.81 |
$14,480 |
D/D |
8,000 |
172,320 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
294,432 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
391,463 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
212,705 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-03-13 |
4 |
D |
$43.22 |
$408,170 |
D/D |
(9,444) |
387,377 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-11 |
4 |
S |
$78.26 |
$767,105 |
D/D |
(9,802) |
203,705 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
AS |
$65.28 |
$698,039 |
D/D |
(10,693) |
171,526 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
OE |
$1.81 |
$19,354 |
D/D |
10,693 |
182,219 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,833 |
194,024 |
0 |
- |
|
113 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
